Postoperative adjuvant chemotherapy after radical hepatic resection for hepatocellular carcinoma (HCC)

Hepato-Gastroenterology

Volumn 43, Issue 12, 1996, Pages 1405-1409

  Kohno, H ^a   Nagasue, N ^a   Hayashi, T ^a   Yamanoi, A ^b   Uchida, M ^a   Ono, T ^a   Yukaya, H ^b   Kimura, N ^b   Nakamura, T ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b Hiroshima Red Cross Atomic Bomb Hospital   (Japan)

Author keywords

Chemotherapy; Hepatectomy; Hepatocellular carcinoma

Indexed keywords

EPIRUBICIN; UFT;

ADULT; AGED; ALOPECIA; ANOREXIA; ARTICLE; BOLUS INJECTION; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG EFFICACY; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOTHERAPY, ADJUVANT; DRUG COMBINATIONS; EPIRUBICIN; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 0030443972     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Franco D, Borgonovo G: Liver resection in cirrhosis of the liver. In: Surgery of the Liver and Biliary Tract (second edition), Blumgart, L.H. (eds), London, Churchill Livingstone,1994, pp 1539-1555.
2. Maehara Y, Watanabe A, Kakeji Y, Baba H, Kohnoe S, Sugimachi K: Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma. Am. J. Surg. 1990; 160: 242-244.
3. Epirubicin study group for hepatocellular carcinoma: Intra-arterial administration of epirubicin in the treatment of nonresectable hepatocellular carcinoma. Cancer Chemother. Pharmacol.1987; 19: 183-189.
4. Nagause N, Kohno H, Chan YC, Taniura H, Yamanoi A, Uchida M, Kimoto T, Takemoto Y, Nakamura T, Yukaya H: Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann. Surg. 1993; 217: 375-384.
5. Edmondson HA, Steiner PE: Primary carcinoma of the liver. A stiidy of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503.
6. Couinaud C: Le Foie. Etudes Anatomiques et Chirurgicales. New York, Masson Publishers,1957.
7. Kajanti M, Pyrhönen S, Mäntylä M, Rissanen P: Intra-arterial and intravenous use of 4' epidoxorubicin combined with 5-fluorouracil in primary hepatocellular carcinoma. A randomized comparison. Am. J. Oncol. (CCT) 1992; 15: 37-40.
8. Kanematsu T, Takenaka K, Matsumata T, Furuta T, Sugimachi K, Inokuchi K: Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann. Surg. 1984; 199: 51-56.
9. Harada A, Nonami T, Kishimoto W, Nakano A, Takagi H: Results of hepatic resection and postoperative arterial chemotherapy for hepatocellular carcinoma. Cancer Chemother. Pharmacol. 1992; 31 Suppl. I: 535-537.
10. Stone MJ, Kintmalm GBG, Polter D, Husberg BS, Mennel RG, Ramsy MAE, Flemens EF, Goldstein RM: Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma. A pilot study in 20 patients. Gastroenterology 1993; 104: 196-202.
11. Huang C, Wu M, Xu G, Li D, Cheng H, Tu Z, Jiang H, Gu J: Overexpression of MDR 1 gene and p-glycoprotein in human hepatocellular cancer. J. Natl. Cancer Inst. 1992; 84: 262-264.